Related references
Note: Only part of the references are listed.The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: A comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer
Jesco Pfitzenmaier et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2007)
Detection and characterization of putative metastatic precursor cells in cancer patients
Catherine Alix-Panabieres et al.
CLINICAL CHEMISTRY (2007)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
HER-2 gene amplification can be acquired as breast cancer progresses
SD Meng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Therapy induced regressive changes of prostate cancer
B Helpap et al.
PATHOLOGE (2004)
From latent disseminated cells to overt metastasis:: Genetic analysis of systemic breast cancer progression
O Schmidt-Kittler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Can nomograms derived in the US applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy
M Graefen et al.
UROLOGE A (2003)
High-resolution genomic profiling of occult micrometastatic tumor cells
J Kraus et al.
GENES CHROMOSOMES & CANCER (2003)
Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables
M Graefen et al.
EUROPEAN UROLOGY (2003)
Prostate carcinoma and the Lambert-Eaton myasthenic syndrome
B Delahunt et al.
JOURNAL OF UROLOGY (2003)
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
CA Klein et al.
LANCET (2002)
Lessons learnt about early prostate cancer from large scale databases: population-based pearls of wisdom
DF Penson et al.
SURGICAL ONCOLOGY-OXFORD (2002)
Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors
O Solakoglu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: Prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
TA Stamey et al.
JOURNAL OF UROLOGY (2002)
Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer
FJ Bianco et al.
PROSTATE (2001)
Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer
MW Kattan et al.
UROLOGY (2001)
Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer:: Detection and prognostic value
D Weckermann et al.
JOURNAL OF UROLOGY (2001)
Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: Biochemical and pathological effects
ME Gleave et al.
JOURNAL OF UROLOGY (2001)
Interobserver reproducibility of Gleason grading of prostatic carcinoma: General pathologists
WC Allsbrook et al.
HUMAN PATHOLOGY (2001)
Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma
J Köllerman et al.
EUROPEAN UROLOGY (2000)
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
